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Abstract
Biofilms are sessile communities of microbial cells embedded in a self-produced or host-derived 
exopolymeric matrix. Biofilms can both be beneficial or detrimental depending on the surface. 
Compared to their planktonic counterparts, biofilm cells display enhanced resistance to killing by 
environmental threats, chemicals, antimicrobials and host immune defenses. When in biofilms, the 
microbial cells interact with each other and with the surface to develop architecturally complex 
multidimensional structures. Numerous imaging techniques and tools are currently available for 
architectural analyses of biofilm communities. This allows examination of biofilm development 
through acquisition of three-dimensional images that can render structural features of the sessile 
community. A frequently utilized tool is Confocal Laser Scanning Microscopy. We present a 
detailed protocol to grow, observe and analyze biofilms of the respiratory human pathogen, 
Bordetella pertussis in space and time.
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[Background]
Bordetella pertussis is an obligate human pathogen of the upper respiratory tract that causes 
whooping cough or pertussis (Mooi, 2010; Dorji et al., 2018). Biofilms of B. pertussis form 
on a variety of artificial surfaces and under static, shaking, and fluid flow conditions (Mishra 
et al., 2005; Sloan et al., 2007; Serra et al., 2011). Microscopic evaluation of these biofilms 
shows that this bacterium produces irregularly shaped microcolonies separated by fluid 
channels, embedded in an exopolymeric matrix composed by extracellular DNA (eDNA), 
proteins and polysaccharides (Parise et al., 2007; Sloan et al., 2007; Serra et al., 2008; 
Conover et al., 2011; Nicholson et al., 2012; Ganguly et al., 2014; Cattelan et al., 2017). In 
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addition to forming biofilms in the laboratory setting, B. pertussis forms multidimensional 
organ-adherent biofilms on the nose and trachea during experimental infections of mice. 
Development of these mammalian biofilms is characterized by an extracellular polymeric 
matrix composed of eDNA, the Filamentous hemagglutinin protein and the Bps 
polysaccharide (Conover et al., 2010 and 2011; Serra et al., 2011; Dorji et al., 2018). Based 
on these results, biofilm formation has been proposed by us and others as a possible strategy 
adopted by B. pertussis to infect, persist and continually circulate in the community 
(Cattelan et al., 2016). Consistent with this hypothesis, we found that currently circulating 
strains from Argentina and USA produce significantly higher levels of biofilms when 
compared to a laboratory reference strain and colonize the mouse nose and trachea at higher 
numbers than the prototype laboratory strain (Cattelan et al., 2017). These results also 
provide evidence that hyperbiofilm growth is a strategy employed by circulating organisms 
to infect and survive inside their host.
In order to study the mechanisms involved in biofilm development, microscopic evaluation 
is a key technique that allows differentiation of the steps of the process, from adhesion to 
maturation and dispersion. In particular, confocal laser scanning microscopy (CLSM) is 
frequently used because it allows visualization of architectural complexities of intact and 
hydrated biofilms. In this protocol, we describe how to grow and process samples of B. 
pertussis biofilms, as demonstrated in our recent publication (Cattelan et al., 2017).
Materials and Reagents
1. 0.2 μm filter
2. Bacteriological Petri plates (Fisher Scientific, catalog number: FB0875712)
3. Sterile test tubes (17 × 100 mm, RPI, Research Products International, catalog 
number: 168599)
4. Serological pipettes:
5 ml pipette (SARSTEDT, catalog number: 86.1253.001)
25 ml pipette (SARSTEDT, catalog number: 86.1685.001)
5. Nalgene™ 2 ml cryogenic tubes (Thermo Fisher Scientific, Thermo Scientific™, 
catalog number 5000–0020)
6. Coverglasses, 22 × 22 mm (Fisher Scientific, Fisherbrand™, catalog number: 
12–542B)
7. Nunc™ 6-wells plates (Thermo Fisher Scientific, Thermo Scientific™, catalog 
number: 150239)
8. Aluminum foil
9. Microscope slides (Fisher Scientific, Fisherbrand™, catalog number: 12–552-3)
10. Sterile disposable plastic material:
Posi-Click tubes (Denville Scientific, catalog number: C2170)
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P200 and P1000 tips (USA Scientific, catalog numbers: 1111–0706 and 1112–
1720)
11. B. pertussis strain harboring a pGB5P1-GFP plasmid
12. Defibrinated sheep’s blood (Hemostat Laboratories, catalog number: DSB100)
13. 50% glycerol solution (Fisher Scientific, catalog number: G33–1)
14. Kanamycin (Sigma-Aldrich, catalog number: K1377)
15. Neutralized buffered formalin (Fisher Scientific, catalog number: SF100–4)
16. Stainer-Scholte medium (Stainer et al., 1970; Nicholson et al., 2012)
17. Sterile PBS (Thermo Fisher Scientific, Gibco™, catalog number: 14190144)
18. ProLong™ Gold Antifade Mountant (Thermo Fisher Scientific, Invitrogen™, 
catalog number: P36934)
19. Difco™ Bordet-Gengou agar plates (BD, BD Biosciences, catalog number: 
248200)
20. L-Proline (Sigma-Aldrich, catalog number: 131547)
21. KH2PO4 (Sigma-Aldrich, catalog number: V000225)
22. KCl (Sigma-Aldrich, catalog number: P3911)
23. MgCl2-6H2O (Sigma-Aldrich, catalog number: M2393)
24. CaCl2 (Sigma-Aldrich, catalog number: C1016)
25. Tris base (Sigma-Aldrich, catalog number: T1378)
26. NaCl (Sigma-Aldrich, catalog number: S7653)
27. FeSO4-7H2O (Sigma-Aldrich, catalog number: F8633)
28. L-cystine (Sigma-Aldrich, catalog number: C8755)
29. L-ascorbic acid (Sigma-Aldrich, catalog number: A5960)
30. Nicotinic acid (Sigma-Aldrich, catalog number: PHR1276)
31. Reduced L-glutathione (Sigma-Aldrich, catalog number: G4251)
32. SS medium (see Recipes)
33. SS supplement (filter-sterilized) (see Recipes)
34. Bordet-Gengou (BG) medium (see Recipes)
Equipment
1. Kimax® Erlenmeyer flasks (125 ml) (DWK Life Sciences, KIMBLE®, catalog 
number: 26500)
2. Sterile forceps
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3. PIPETMAN® Classic (Gilson, models: P20, P200, P1000, catalog numbers: 
F123600, F123601, F123602)
4. Humid chamber (an appropriately sized Tupperware container with either a 
weigh boat containing water or paper towels soaked with water)
5. Chemical fume hood (Hamilton Laboratory Solutions, model: PL-822)
6. Eclipse Ti-E inverted Confocal Microscope (Nikon, model: D-Eclipse C1si)
7. Vortex (Fisher Scientific, catalog number: 02–215-365)
8. pH meter (Denver Instrument, model: UB-10)
9. Incubator (Thermo Fisher Scientific, Thermo Scientific™, model: Forma™ 
Steri-Cycle™)
10. Benchtop centrifuge (Eppendorf, model: 5418)
11. Refrigerator (4 °C) (Whirlpool, model: WRR56X18FW02)
12. −20 °C freezer (Kenmore, model: 253–26722103)
13. SPECTRONIC™ Spectrophotometer (Thermo Fisher Scientific, model: 
GENESYS 20)
14. Weigh Balance (Ohaus, model: Scout Pro SP202 and VWR, model: 
VWR-164AC)
15. Roller Drum (Eppendorf, New Brunswick™, model: TC-2)
Software
1. ImageJ (Schneider et al., 2012)
2. COMSTAT2 plugin (Heydorn et al., 2000)
Procedure
Notes:
a. The entire protocol is depicted in Figure 1.
b. Samples should be protected from light during the experiment. In all cases, 
medium is supplemented with appropriate antibiotic to maintain the plasmid 
coding for GFP.
A. Growth of B. pertussis strains
1. From frozen stock stored at −78 °C, streak B. pertussis strains 
harboring a GFP-coding plasmid, pGB5P1-GFP was used in this 
protocol (Weingart et al., 1999), on Bordet-Gengou agar plates 
supplemented with 10% defibrinated sheep’s blood and 25 μg/ml of 
kanamycin. Incubate the plates at 37 °C for 4–5 days.
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2. Pick individual colonies (~8–10) and inoculate 2 ml of Stainer-Scholte 
(SS) liquid medium supplemented with 25 μg/ml of kanamycin. 
Incubate at 37°C in a roller drum spinning at top speed for 24 h.
3. Inoculate 30 ml of SS medium supplemented with 25 μg/ml of 
kanamycin (in a 100 ml Erlenmeyer flask), with the cultures from Step 
A2 to achieve an OD650 of 0.2. Incubate for 12 h at 37 °C with shaking 
at 160 rcf.
B. In vitro biofilm formation
1. Insert a sterile coverglass (flame sterilized) at the bottom of sterile 6-
well plates.
2. Prepare inoculum by diluting B. pertussis culture (Procedure A, Step 3) 
to an OD650 of 1.0 in SS medium. Pipet 1.5 ml of inoculum into 
individual wells of the 6-well plates. Make sure the bacterial suspension 
is covering the entire surface of the coverslip. In case other substrates 
are used (i.e., polycarbonate or aluminum coupons), volume should be 
adjusted according to the thickness of the material.
3. Cover the plate and incubate statically in a humidified chamber for 4 h 
at 37 °C.
Note: This step allows the adhesion of bacteria to the surface.
4. Remove inocula (to allow removal of unattached planktonic bacteria) 
carefully without disturbing attached cells and add approximately 800 
μl of fresh SS medium, dispensing along the wall of the well to prevent 
biofilm disruption. Place the plate at an angle of 30°−50° relative to 
horizontal, forming an air-liquid interface in the coverglass where 
biofilms will develop. Cover the plate with aluminum foil and incubate 
in a humidified chamber at 37 °C on a platform shaker at 90 rcf.
5. If the biofilm formation is going to be examined for longer than 24 h, 
change medium every 24 h as described above. Samples can be 
processed at 24, 48, and 72 up to 96 h.
C. Visualization of biofilms
1. After each time point, aspirate medium from each well and carefully 
wash the biofilms twice with sterile PBS.
2. Pick the coverglass up with forceps and place it into a new 6-well plate. 
A needle can be used to aid in lifting the coverglass followed by use of 
forceps to pick the coverglass without touching the area where the 
biofilm developed.
3. Carefully add 50 μl of neutral buffered formalin, or enough to cover the 
glass surface. Special attention must be taken in order to not disturb the 
biofilm and incubate for 15 min at room temperature.
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4. Remove fixative and wash twice with PBS.
5. Pick the coverglass up with forceps and mount onto a glass slide with 
ProLong™ Gold mounting media. Alternatively, if bacteria are not 
labeled with a fluorescent protein, cells can be stained at this point with 
a fluorescent dye and then mounted.
6. Allow the mounting media to harden by incubating at 4 °C for 24 h.
7. Slides can be stored (weeks to months) in the dark at room temperature 
for later visualization. Examine the samples with a confocal 
microscope, taking images in a z-stack configuration, making sure to 
cover the entire biofilm structure from bottom to top.
8. Analyze the images by using microscopy image visualization software 
(Figure 2).
Data analysis
Quantitative data from images can be obtained with COMSTAT2 plug-in (Heydorn et al., 
2000) run in ImageJ (Schneider et al., 2012). Structural features that can be analyzed are 
maximum and average thicknesses, substrate coverage, biomass and roughness coefficient 
(see structural data in Table 1). Detailed instructions for COMSTAT2 use are described in 
Heydorn et al. (2000). Appropriate statistical analysis should be carried out on the obtained 
data.
Notes
1. Due to variations observed with this assay, there is need to be performed with 
duplicates of each sample and at least three independent replicates. For each 
sample, at least three representative images should be acquired.
2. A critical consideration is not to disrupt the biofilm attached to the glass surface. 
Depending on the microorganism, cells may attach either strongly or loosely to 
surfaces. Thus it is important to be extremely careful while dispensing liquid to 
avoid strong shear forces.
3. BG-agar medium and SS medium are sterilized by autoclaving at 121 °C for 15 
min.
4. To prepare a cryogenic stock, cultures grown to exponential phase (set up as 
explained in Step A2) should be used. Use sterile 2 ml cryogenic tubes and mix 
500 μl of bacterial culture with 500 μl of sterile 50% glycerol solution. Store at 
−78 °C.
Recipes
Note: Unless otherwise indicated, all stock solutions are prepared using Milli Q water.
1. SS medium
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Tris base: 1.52 g/L
NaCI: 2.50 g/L
Adjust to pH 7.3–7.4 with HCI
2. SS supplement (0.2 μm filter-sterilized)
Dissolve in HCI concentrated, and then filter sterilize
FeS04.7H20: 10 mg/L
L-cystine: 40 mg/L
L-ascorbic acid: 20 mg/L
Nicotinic acid: 4 mg/L
Reduced L-glutathione: 100 mg/L
3. Bordet-Gengou (BG) medium
Difco™ Bordet-Gengou agar (30 g/L)
20 ml of 50% glycerol
Autoclave at 121 °C for 15 min
Aseptically add 15% sterile, defibrinated blood to the medium at 45–50 °C
Mix well and plate
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Schematic step-by-step protocol for growing B. pertussis biofilms for CLSM evaluation
Cattelan et al. Page 9









Figure 2. Micrographs of a B. pertussis biofilm.
Biofilms were grown from 24 up to 96 h and images were acquired in an inverted confocal 
microscope in a z-stack setting. Images are presented in xy, xz and yz planes.
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Table 1.
Biofilm structural features of the images presented in Figure 2, obtained with COMSTAT2 software
24 h 48 h 72 h 96 h
Biomass (μm3/μm2) 2.05 3.70 5.73 4.41
Average thickness (μm) 5.62 12.20 20.78 15.66
Maximum thickness (μm) 7.00 18.00 28.00 19.00
Roughness coefficient 1.10 1.06 1.04 1.06
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